ACCUMULATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN CULTURED CEREBELLAR ASTROCYTES

被引:20
作者
MARINI, AM
LIPSKY, RH
SCHWARTZ, JP
KOPIN, IJ
机构
[1] NINCDS,CLIN NEUROSCI BRANCH,BETHESDA,MD 20892
[2] AMER RED CROSS,JEROME HOLLAND LAB,CELL BIOL LAB,ROCKVILLE,MD
关键词
CEREBELLAR ASTROCYTES; LYSOSOMAL BINDING; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; LYSOSOMOTROPIC; 1-METHYL-4-PHENYL-PYRIDINIUM;
D O I
10.1111/j.1471-4159.1992.tb11336.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cultured cerebellar astrocytes rapidly accumulate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) from the incubation medium, reaching a plateau within 10 min, whereas within that time negligible amounts of 1-methyl-4-phenylpyridinium (MPP+) have entered the astrocytes. MPTP accumulation is essentially independent of temperature and is proportional to extracellular concentration at steady state: The steady-state concentration achieved within these cells is about 50-fold higher at relatively low extracellular concentrations. MPTP appears to accumulate intracellularly within lysosomes, because lysosomotropic agents such as ammonium chloride and chloroquine markedly diminish the accumulation. Moreover, a proton gradient is required, because MPTP accumulation is abolished by the hydrogen ion antiporter monensin. Over an interval of several days, MPTP is converted to MPP+ intracellularly, with a concomitant decrease in medium MPTP and increase in medium MPP+. A constant, small but significant amount of MPP+ is retained intracellularly over a 72-h interval. Increasing the medium MPTP concentrations results in increased conversion of MPTP and enhanced intracellular retention of MPTP and MPP+. Neither MPTP nor MPP+ is neurotoxic to cultured cerebellar astrocytes as determined by cell counts and rate of conversion of MPTP to MPP+.
引用
收藏
页码:1250 / 1258
页数:9
相关论文
共 37 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   ASTROCYTES AS A PRIMARY LOCUS FOR THE CONVERSION MPTP INTO MPP [J].
BROOKS, WJ ;
JARVIS, MF ;
WAGNER, GC .
JOURNAL OF NEURAL TRANSMISSION, 1989, 76 (01) :1-12
[3]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[4]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[5]   PARGYLINE AND DEPRENYL PREVENT THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MONKEYS [J].
COHEN, G ;
PASIK, P ;
COHEN, B ;
LEIST, A ;
MYTILINEOU, C ;
YAHR, MD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (01) :209-210
[6]   EVIDENCE FOR NEUROMELANIN INVOLVEMENT IN MPTP-INDUCED NEUROTOXICITY [J].
DAMATO, RJ ;
ALEXANDER, GM ;
SCHWARTZMAN, RJ ;
KITT, CA ;
PRICE, DL ;
SNYDER, SH .
NATURE, 1987, 327 (6120) :324-326
[7]   LYSOSOMOTROPIC AGENTS [J].
DEDUVE, C ;
DEBARSY, T ;
POOLE, B ;
TROUET, A ;
TULKENS, P ;
VANHOOF, F .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (18) :2495-+
[8]  
FULLER RW, 1985, LIFE SCI, V37, P1096
[9]   MONOAMINE-OXIDASE TYPE-A - DIFFERENCES IN SELECTIVITY TOWARDS L-NOREPINEPHRINE COMPARED TO SEROTONIN [J].
GARRICK, NA ;
MURPHY, DL .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (24) :4061-4066
[10]   NEUROTOXICITY OF THE MEPERIDINE ANALOG N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE ON BRAIN CATECHOLAMINE NEURONS IN THE MOUSE [J].
HALLMAN, H ;
OLSON, L ;
JONSSON, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 97 (1-2) :133-136